Resolution of left and right ventricular thrombosis secondary to hypereosinophilic syndrome (lymphoproliferative variant) with reduced intensity conditioning allogenic stem cell transplantation.
Juan M
JM
Bergua
Elena
E
Prieto-Pliego
Alejandro
A
Román-Barberá
José
J
García-Torón
José Javier
JJ
Gómez-Barrado
Gonzalo
G
Marcos
Luis
L
López-Gómez
José F
JF
Tomás
D000328:Adult; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000150:complications* / Q000628:therapy; D016411:Lymphoma, T-Cell, Peripheral / Q000150:complications* / Q000628:therapy; D011089:Polydeoxyribonucleotides / Q000627:therapeutic use*; D013927:Thrombosis / Q000188:drug therapy* / Q000209:etiology; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous; D018487:Ventricular Dysfunction, Left / Q000209:etiology; D018497:Ventricular Dysfunction, Right / Q000209:etiology
D005343:Fibrinolytic Agents; D011089:Polydeoxyribonucleotides; C036901:defibrotide